Production of a pokeweed antiviral protein (PAP)-containing immunotoxin, B43-PAP, directed against the CD19 human B lineage lymphoid differentiation antigen in highly purified form for human clinical trials
Dorothea E. Myers, James D. Irvin, Ron S. Smith, Virginia M. Kuebelbeck, Fatih M. UckunVolume:
136
Year:
1991
Language:
english
DOI:
10.1016/0022-1759(91)90009-5
File:
PDF, 1.30 MB
english, 1991